Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Context Therapeutics Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +6 vs. Q3 2025
- Shares held
- 65.3M
- −3.67M (−5.3%) vs. Q3 2025
- Total value
- $96.0M
- +$29.2M (+43.7%) vs. Q3 2025
- New holders
- 10
- 8 more added
- Sold out
- 4
- 8 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 114 | $168 | 0.00% | −3−2.6% | Reduced |
| UBS Group AG | 490 | $720 | 0.00% | −6,892−93.4% | Reduced |
| Bank of America Corp | 933 | $1.37K | 0.00% | +499+115.0% | Added |
| Citigroup Inc | 1,348 | $1.98K | 0.00% | +1,348 | New |
| Farther Finance Advisors, LLC | 1,500 | $2.21K | 0.00% | +1,500 | New |
| Strive Financial Group ,LLC | 1,700 | $2.50K | 0.00% | +1,700 | New |
| Tower Research Capital LLC (TRC) | 9,611 | $14.1K | 0.00% | +9,611 | New |
| CI Private Wealth, LLC | 15,084 | $22.2K | 0.00% | +15,084 | New |
| Caxton Corp | 18,403 | $27.1K | 0.63% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $29.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25,500 | $37.5K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 28,921 | $43.0K | 0.00% | +28,921 | New |
| Citadel Advisors LLC | 34,380 | $50.5K | 0.00% | −68,983−66.7% | Reduced |
| Nantahala Capital Management, LLC | 37,837 | $55.6K | 0.00% | −1,624,113−97.7% | Reduced |
| Quadrature Capital Ltd | 46,220 | $67.9K | 0.00% | +46,220 | New |
| Point72 Asset Management, L.P. | 52,701 | $77.5K | 0.00% | +52,701 | New |
| Northern Trust Corp | 84,281 | $123.9K | 0.00% | +17,897+27.0% | Added |
| Clear Harbor Asset Management, LLC | 92,804 | $136.4K | 0.01% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 100,000 | $147.0K | 0.09% | 00.0% | Unchanged |
| Deeter Investments LLP | 100,000 | $147.0K | 0.03% | +100,000 | New |
| XTX Topco Ltd | 101,605 | $149.4K | 0.00% | +91,008+858.8% | Added |
| Mill Creek Capital Advisors, LLC | 104,631 | $153.8K | 0.00% | 00.0% | Unchanged |
| Pathstone Holdings, LLC | 110,244 | $162.1K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 125,852 | $185.0K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 132,786 | $195.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 165,607 | $243.4K | 0.00% | +13,000+8.5% | Added |
| ADAR1 Capital Management, LLC | 351,094 | $516.1K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 508,329 | $747.2K | 0.00% | +188,202+58.8% | Added |
| Geode Capital Management, LLC | 608,462 | $894.9K | 0.00% | −1150.0% | Reduced |
| BlackRock, Inc. | 848,046 | $1.25M | 0.00% | −924−0.1% | Reduced |
| Sio Capital Management, LLC | 1,341,636 | $1.97M | 0.33% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 1,663,355 | $2.45M | 0.01% | 00.0% | Unchanged |
| Blackstone Group Inc. | 2,440,330 | $3.59M | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 2,593,198 | $3.81M | 0.00% | +2,557,448+7,153.7% | Added |
| Millennium Management LLC | 2,601,216 | $3.82M | 0.00% | +2,601,216 | New |
| Vanguard Group Inc | 3,785,909 | $5.57M | 0.00% | +290,878+8.3% | Added |
| Franklin Resources Inc | 4,003,380 | $5.88M | 0.00% | 00.0% | Unchanged |
| Great Point Partners LLC | 4,683,711 | $6.89M | 2.23% | 00.0% | Unchanged |
| Avidity Partners Management LP | 5,504,855 | $8.09M | 2.33% | −3,477,000−38.7% | Reduced |
| Nextech Invest, Ltd. | 7,419,355 | $10.9M | 1.05% | 00.0% | Unchanged |
| Deep Track Capital, LP | 7,419,355 | $10.9M | 0.25% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 7,432,906 | $10.9M | 3.37% | +25,000+0.3% | Added |
| MPM Oncology Impact Management LP | 10,679,391 | $15.7M | 1.80% | −4,026,491−27.4% | Reduced |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −402,653−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −82,111−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −21,967−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |